Horan Capital Advisors LLC. Has $660,000 Holdings in Aflac Incorporated (NYSE:AFL)

Horan Capital Advisors LLC. trimmed its stake in Aflac Incorporated (NYSE:AFL) by 5.6% in the fourth quarter, HoldingsChannel reports. The firm owned 6,378 shares of the financial services provider’s stock after selling 378 shares during the period. Horan Capital Advisors LLC.’s holdings in Aflac were worth $660,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the business. Whipplewood Advisors LLC purchased a new position in shares of Aflac in the fourth quarter worth about $26,000. Darwin Wealth Management LLC purchased a new stake in shares of Aflac in the 3rd quarter worth about $34,000. BankPlus Trust Department purchased a new stake in Aflac during the 4th quarter valued at about $34,000. Raelipskie Partnership bought a new position in Aflac during the 3rd quarter valued at about $38,000. Finally, Covestor Ltd lifted its stake in shares of Aflac by 41.8% in the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after purchasing an additional 107 shares during the period. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

AFL has been the subject of a number of research analyst reports. JPMorgan Chase & Co. increased their price objective on shares of Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a report on Tuesday, January 7th. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. Piper Sandler dropped their price objective on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. Morgan Stanley lifted their target price on Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Friday. Finally, Evercore ISI decreased their target price on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research report on Wednesday, December 4th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $103.36.

Insider Activity

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the company’s stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the sale, the executive vice president now directly owns 222,618 shares in the company, valued at $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.90% of the company’s stock.

Aflac Trading Up 0.5 %

AFL opened at $110.00 on Tuesday. The firm has a market cap of $61.11 billion, a price-to-earnings ratio of 11.46, a price-to-earnings-growth ratio of 3.24 and a beta of 0.99. Aflac Incorporated has a 52 week low of $78.62 and a 52 week high of $115.50. The business’s 50 day moving average is $104.71 and its two-hundred day moving average is $107.65. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, research analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.